www.aristea.com/acscrossroads

BAVENO, ITALY - OCTOBER 10/11, 2014V INTERNATIONAL ACS CROSSROADS

PROGRAM

A. MENARINI • BAYER • BOSTON SCIENTIFICBRISTOL-MYERS SQUIBB • ORBUS • PFIZER • PRO.MED • SANITEX

Supported by unrestricted educational grants from:

14.30 Welcome and Introduction

SESSION IUPDATE ON ORAL ANTIPLATELET THERAPIESChairmen: G. De Luca, F. Piscione

15.30 Resistance to aspirin and ADP-antagonists: Mechanism, prevalence and clinical relevance - M. Cattaneo

15.40 Update on pharmacological gastroprotection:when and how - G. Belli

15.50 Switching from clopidogrel to new ADP antagonist: When and how - G. Parodi

16.00 ACCOAST Study: is an upstream strategy still necessary? - J.P. Collet

16.10 Ticagrelor and its pleiotropic effects - D. Ardissino

16.20 Optimal duration of DAPT - G. De Luca

16.30 MODERATED DISCUSSIONDiscussants: M. Ferlini, G. Galasso, A. Mafrici,

M. Napodano, U. Zeymer

SESSION II TRIPLE ORAL THERAPY IN ACS: WHAT HAS BEEN DONE AND WHAT’S GOING ON!Chairmen: J.P. Collet, D. Dudek

16.45 Rationale for Triple therapy in ACS - G. Galasso

16.55 PAR-1 Antagonists - F. Varbella

17.05 Factor Xa Inhibitors - A. Mafrici

17.15 MODERATED DISCUSSIONDiscussants: G. Galasso, G. Musumeci, G. Parodi,

F. Piscione, G.G. Secco

SESSION III FLASH DEBATE: OPTIMAL ANTITHROMBOTIC THERAPY IN STEMI WITH NEW ORAL ADP ANTAGONISTS Chairmen: K. Huber, G. Parodi

17.30 Gp IIb-IIIa inhibitors - G. De Luca

17.40 Bivalirudin - D. Dudek

17.55 Cangrelor: a new player? - A. Rognoni

18.05 MODERATED DISCUSSIONDiscussants: A. Lupi, M. Romano, G. Tarantini,

F. Varbella, U. Zeymer

SESSION IV YOUNG INTERVENTIONALIST COMPETITION: MY WORST COMPLICATION IN THE CATH LAB! Chairmen: D. Antonucci, D. DudekDiscussants: G. Belli, M. D’Amico, P. Gaetano,

M. Romano, P. Silva, H. Thiele

19.20 LECTURENew ADP antagonists and Gp IIb-IIIa inhibitors in ACS: when and how to use - J.P. Collet

DAY 1 - FRIDAY, OCTOBER 10, 2014

SESSION V ANTIPLATELET THERAPY AND SURGERY Chairmen: P. Marino, L. Oltrona-Visconti

08.30 Need of surgery under dual antiplatelet therapy:Prevalence and Outcome - S. De Servi

08.40 Current status on Bridge therapy - S. Savonitto

08.50 The Italian consensus document - G. Musumeci

09.00 SAS Registry - R. Rossini

09.10 MODERATED DISCUSSIONDiscussants: M. Commodo, M. D’Urbano, F. Grassi,

E. Passamonti, A. Rognoni, C. Sponzilli,

SESSION VIFLASH DEBATE: THROMBECTOMY IN 2014 Chairmen: K. Huber, H. Suryapranata

09.25 No proof for routine thrombectomy - S. James

09.35 No power no party: go for rheolytic thrombectomy - D. Antoniucci

09.45 MODERATED DISCUSSIONDiscussants: R. Garbo, E. Kedhi, E. Meliga,

R. Moreno, G.G. Secco, A. Silvestro

SESSION VIIANTITHROMBOTIC MANAGEMENT OF ACS PATIENTS WITH ATRIAL FIBRILLATION Chairmen: S. James, R. Moreno

10.00 Prevalence and management of AF in ACS - F. Saia

10.10 Triple therapy: The WOEST study - E. Kedhi

10.20 New Oral Anticoagulants and new ADP-antagonists: how do they fit? - K. Huber

10.30 New stent strategies - E. Meliga

10.40 MODERATED DISCUSSIONDiscussants: G. Boccuzzi, D. Capodanno,

P. Colombo, M. Ferlini, P. Gaetano, H. Thiele

11.00 Coffee break

SESSION VIII TAVI: THE NEW HORIZONS Chairmen: S. Berti, G. Pedrazzini

11.30 Balloon expandable valves: what’s new - G. Napodano

11.40 TAVI for aortic regurgitation: current data and future indications - L. Testa

11.50 New valves - F. De Marco

12.00 DISCUSSIONDiscussants: G. Bruschi, P. Colombo,

M. Commodo, C. Moretti,M. Napodano, F. Saia, M. Tespili

DAY 2 - SATURDAY, OCTOBER 11, 2014

SESSION IX YOUNG INTERVENTIONALIST COMPETITION: MY WORST COMPLICATION IN THE CATH LAB! Chairmen: R. Garbo, M. Tespili

13.00 LECTUREMechanical support for cardiogenic shock: from the present to the future - H. Thiele

13.30 Lunch

POSTER SESSION

SESSION X BEYOND THROMBOSIS AND REVASCULARIZATION.NEW DRUGS IN THE ARENA Chairmen: G. De Luca, G. Parodi

14.30 Ranolazine: rationale, current data and ongoing trials - F. Pelliccia

14.40 HDL and CETP inhibitors - L. Calabresi

14.50 Erectile dysfunction: prevalence, prognostic implications and therapeutic approach - F. Lanfranco

15.00 MODERATED DISCUSSIONDiscussants: G. Galasso, A. Lupi, G.G. Secco

SESSION XI DES IN ACS: 2014 UPDATE Chairmen: A.S. Bongo, D. Antoniucci

15.20 Dual-therapy stent - H. Suryapranata

15.30 Self-expanding stent - D. Capodanno

15.40 Bioabsorbable polymer with everolimus - R. Moreno

15.50 Hybrid DES - G.G. Secco

16.00 CoCr SES with hydrophilic coating and Bioabsorbable polymer - G.B. Danzi

16.10 Polymer-free SES and stainless steel SES with Bioabsorbable polymer - G. De Luca

16.20 BVS: when and how - G. Boccuzzi

16.30 IVUS for optimal stenting: routine or selective use? - A. Lupi

16.40 MODERATED DISCUSSIONDiscussants: L. Golino, E. Piccaluga,

A. Rognoni, G. Tarantini

17.00 LECTUREmiRNAs and cardiovascular disease: state-of-the-art - L. EliaPresenter: G. De Luca

17.30 CEREMONYWinners of Young Investigator competitions

18.00 Conclusions

DAY 2 - SATURDAY, OCTOBER 11, 2014

J.P. Collet Paris, France

D. Dudek Krakow, Poland

K. Huber Vienna, Austria

S. James Upssala, Sweden

E. Kedhi Zwolle, The Netherlands

R. Moreno Madrid, Spain

M. Noc Ljiubiana, Slovenia

G. Pedrazzini Lugano, Switzerland

H. Suryapranata Nijmegen, The Netherlands

H. Thiele Leipzig, Germany

A.W.J. van’t Hof Zwolle, The Netherlands

U. Zeymer Ludwigshafen, Germany

F. Airoldi Milan

D. Antoniucci Florence

D. Ardissino Parma

G. Belli Bergamo

S. Berti Massa

G. Boccuzzi Turin

L. Bolognese Arezzo

A.S. Bongo Novara

G. Bruschi Milan

L. Calabresi Milan

D. Capodanno Catania

M. Carlino Milan

M. Cattaneo Milan

P. Colombo Milan

M. Commodo Novara

G.B. Danzi Milan

M. D’Amico Torino

M. De Benedictis Turin

G. De Luca Novara

F. De Marco Milan

S. De Servi Pavia

M. D’Urbano Magenta

L. Elia Milan

M. Ferlini Pavia

P. Gaetano Ciriè

G. Galasso Naples

R. Garbo Turin

C. Godino Milan

L. Golino Gravedona

F. Grassi Novara

F. Lanfranco Turin

C. Lettieri Mantova

A. Lupi Novara

A. Mafrici Milan

P. Marino Novara

E. Meliga Turin

C. Moretti Turin

G. Musumeci Bergamo

M. Napodano Padua

L. Oltrona-Visconti Pavi

G. Parodi Florence

E. Passamonti Cremona

F. Pelliccia Rome

E. Piccaluga Milan

F. Piscione Salerno

P. Presbitero Milan

A. Rognoni Novara

M. Romano Mantova

R. Rossini Bergamo

F. Saia Bologna

S. Savonitto Lecco

G.G. Secco Novara

P. Silva Milan

A. Silvestro Seriate

C. Sponzilli Milano

G. Tarantini Padua

M. Tespili Seriate

L. Testa Milan

F. Varbella Turin

INTERNATIONAL FACULTY NATIONAL FACULTY

COURSE DIRECTORSGiuseppe De Luca (Italy)Harry Suryapranata (The Netherlands)

SCIENTIFIC COMMITTEE Giuseppe De Luca (Italy)Harry Suryapranata (The Netherlands)David Antoniucci (Italy)Dariusz Dudek (Poland)Guido Parodi (Italy)

SCIENTIFIC SECRETARYMonica VerdoiaAlon SchafferEttore CassettiLucia BarbieriGabriella Di Giovine Matteo Nardin

CONGRESS VENUEGrand Hotel DinoCorso Garibaldi, 20 • 28831 Baveno • Italy

C.M.E. PROVIDER

Via Roma, 10 • 16121 Genova • ItalyTel. (+39) 010 553591 • Fax (+39) 010 5535970E-mail genova@aristea.com • Web www.aristea.com

C.M.E. Only for Italian ParticipantsIl Congresso è stato inserito da Aristea Education - Provideraccreditato dalla Commissione Nazionale per FormazioneContinua con il numero di accreditamento 500 - nel propriopiano formativo 2014 nell’ambito del Programma NazionaleE.C.M. (Educazione Continua in Medicina). Il Congresso è destinato alle seguenti figure professionali:

Tecnico Sanitario di Radiologia Medica, Medico Chirurgo(Discipline: Cardiologia, Ematologia, Geriatria, MalattieMetaboliche e Diabetologia, Medicina e Chirurgia di Accet-tazione e d’Urgenza, Medicina Interna, Nefrologia, Psichiatria,Cardiochirurgia, Chirurgia Generale, Chirurgia Toracica,Chirurgia Vascolare, Anestesia e Rianimazione, MedicinaGenerale (Medici di Famiglia), Infermiere e riconosce n. 12crediti formativi per 80 partecipanti. L’attestazione dei crediti è subordinata alla partecipazioneeffettiva all’intero programma formativo, nella misura del100%, ed alla verifica dell’apprendimento. L’attestato di partecipazione, riportante il numero di creditiassegnati, verrà pertanto rilasciato dopo avere effettuatotali verifiche e sarà quindi disponibile on-line sul sito webwww.aristea.com 60 giorni dopo la chiusura dell’evento. Per ogni ulteriore informazione si rimanda all’indirizzo webwww.aristea.com/ecm

OBIETTIVO FORMATIVOLinee Guida - Protocolli - Procedure.

ON-LINE REGISTRATIONThe registration is free of charge but mandatory. For on-lineregistration please visit the website of the Congress:www.aristea.com/acscrossroads

ORGANIZING SECRETARIAT

Via Roma, 10 • 16121 Genova • ItalyTel. (+39) 010 553591 • Fax (+39) 010 5535970E-mail acscrossroads@aristea.com • Web www.aristea.com

WEB SITEwww.aristea.com/acscrossroads

GENERAL INFORMATION